Aimee Donnellan

Aimee Donnellan, a columnist and author focusing on Ozempic, delves into how GLP-1 weight-loss drugs work, their potential risks, and the significant impact on obesity treatment. She reveals the drug's biological effects on hunger and cravings and discusses the implications of discontinuation. Meanwhile, David McWilliams, a former central bank economist, explores the fascinating history of money as a social technology, its role in civilization, and the psychological influences it has on our lives. Both guests provide deep insights into contemporary issues affecting health and wealth.

Aimee Donnellan, journalist and author of 'Off the Scales,' dives into the overlooked story of Svetlana Mojsov, a biochemist who discovered GLP-1. Aimee reveals how Mojsov’s groundbreaking work in diabetes treatment was overshadowed, leading to her erasure from a narrative dominated by male accolades. They discuss the complexities of patent disputes, the systemic gender bias in science known as the Matilda effect, and the commercial dynamics surrounding GLP-1 drugs like Ozempic, exposing both their benefits and societal consequences.